Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy | Zendy

Sonia Briese | Zendy; S Wiesner | Zendy; Joachim C. Will | Zendy; Alexander Lembcke | Zendy; Bernd OpgenRhein | Zendy; Richard Nissel | Zendy; Klaus–Dieter Wernecke | Zendy; Judit Andreae | Zendy; Dieter Haffner | Zendy; Uwe Querfeld | Zendy

Open Access

Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy

Author(s) -

Sonia Briese,

S Wiesner,

Joachim C. Will,

Alexander Lembcke,

Bernd OpgenRhein,

Richard Nissel,

Klaus–Dieter Wernecke,

Judit Andreae,

Dieter Haffner,

Uwe Querfeld

Publication year - 2006

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfl098

Subject(s) - medicine , cardiology , kidney disease , end stage renal disease , dialysis , population , coronary artery disease , left ventricular hypertrophy , vitamin d and neurology , renal replacement therapy , hemodialysis , blood pressure , environmental health

Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this population. Hyperphosphataemia and renal osteodystrophy are particularly difficult to treat in paediatric patients, but there is only limited information regarding the effect of calcium-containing phosphate binders and vitamin D preparations on the development of CVD in the young.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research